Company news

SpyGlass Pharma, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

October 19, 2026

SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

October 1, 2026

SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space

August 28, 2026

SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 6, 2026

SpyGlass Pharma Appoints Shannon Treviño as General Counsel

June 15, 2026

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

June 1, 2026

SpyGlass Pharma to Participate in Upcoming Investor Conferences

May 21, 2026

SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

May 18, 2026

SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

May 14, 2026

SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

March 25, 2026

SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

March 8, 2026

SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit

March 3, 2026

SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

February 8, 2026

SpyGlass Pharma Announces Pricing of Initial Public Offering

February 4, 2026

Decks